2025-12-17 - Analysis Report
Here's an analysis of Rocket Lab (RKLB) based on the provided data.

**0. Report Type**

This is a stock analysis report for Rocket Lab USA Inc (RKLB).

**1. Return Rate vs. S&P 500 (VOO) Comparison**

*   **Company Overview:** Rocket Lab USA Inc. is a space launch and services company providing end-to-end mission services.
*   **RKLB Cumulative Return:** 315.87%
*   **VOO (S&P 500) Cumulative Return:** 49.23%
*   **Divergence:**
    *   Current: 279.2
    *   Relative Divergence: 75.5 (Meaning the current divergence is in the top 75.5th percentile of its historical range).

**Analysis of Alpha, Beta, CAGR, MDD Table:**

|            | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2020-2022  | -38.0%  | 82.7%   | -18.0%  | 0.1    | 2.0    |
| 2021-2023  | 3.0%    | 82.7%   | 2.0%    | 0.0    | 3.0    |
| 2022-2024  | 210.0%  | 82.7%   | 189.0%  | 0.0    | 13.6   |
| 2023-2025  | 336.0%  | 79.6%   | 272.0%  | -0.0   | 29.6   |

*   **CAGR (Compound Annual Growth Rate):**  RKLB has shown impressive growth in recent periods (2022-2024 and 2023-2025), especially compared to the initial periods.
*   **MDD (Maximum Drawdown):**  The MDD is consistently high, indicating significant price volatility and risk. While the MDD from 2023-2025 is slightly lower, it still represents a substantial potential loss.
*   **Alpha:** Alpha is exceptionally high in the most recent periods, suggesting strong outperformance relative to the market. This supports the earlier return rate comparison.
*   **Beta:**  Beta is very low (close to 0 or negative), implying that RKLB's price is not strongly correlated with the overall market (S&P 500). This could be due to the company's unique industry or growth stage.
*   **Cap(B) Market Cap:** RKLB's market cap has grown significantly from 2020 to 2025.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 55.49
*   **Previous Close:** 55.41
*   **Change:** 0.14 (a very slight increase)
*   **5-day SMA:** 58.688
*   **20-day SMA:** 48.0273
*   **60-day SMA:** 54.3865

**Analysis:** The current price is below the 5-day SMA but above the 60 day SMA.
The 5-day SMA is above the 60-day SMA.
The 20-day SMA is below the 60 day SMA.
Therefore it can be said the stock has been on an upwards trend in the short and intermediate term.

**3. RSI, PPO Index, Delta_Previous_Relative_Divergence, and Expected Return**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment Recommendation)
*   **RSI (Relative Strength Index):** 70.56 (Approaching overbought territory, suggesting the stock may be due for a pullback)
*   **PPO (Percentage Price Oscillator):** 3.614 (Positive and increasing, indicating bullish momentum)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** 22.1 (+), indicating short-term upward momentum
*   **Price Change:** {'price': 55.49, 'previousClose': 55.41, 'change': 0.14} -  The change is small, indicating no significant recent volatility at this specific point.
*   **Expected Return:** 8.0% (Expected excess return compared to the S&P 500 if invested long-term (more than 2 years).

**Analysis:**
The MRI suggests a moderate investment risk. The RSI indicates that the stock is approaching overbought conditions. However, the positive PPO and the recent relative divergence change point towards continued bullish momentum.  The hybrid signal leans bullish, although with a "Safe" tag due to the MRI. The expected return is positive, suggesting long-term potential.

**4. Recent News & Significant Events**

*   **Themes:** Recent news is mixed.  Several articles highlight the stock's surge following successful missions. However, other articles discuss potential reasons for recent price declines. Analyst opinions and forecasts are also featured.

**4-2. Analyst Opinions**

*   **Mean Target Price:** $65.67 (Suggests potential upside from the current price).
*   **Target Price Range:** $47.00 - $83.00 (Wide range indicating varying analyst perspectives).
*   **Recent Rating Changes:** Not specified (no information provided on recent upgrades/downgrades).

**5. Recent Earnings Analysis**

| Date       | EPS    | Revenue   |
|------------|--------|-----------|
| 2025-11-10 | -0.03  | 0.16 B$   |
| 2025-08-07 | -0.13  | 0.14 B$   |
| 2025-05-08 | -0.12  | 0.12 B$   |
| 2024-11-12 | -0.10  | 0.10 B$   |
| 2025-11-10 | -0.10  | 0.10 B$   |

**Analysis:**

*   **EPS (Earnings Per Share):** Rocket Lab is still not profitable. However, the EPS has improved significantly in the most recent quarter, suggesting progress toward profitability.  (The second 2025-11-10 date appears to be a data duplication).
*   **Revenue:** Revenue has been consistently increasing, which is a positive sign for the company's growth.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $0.16B  | 36.96%        |
| 2025-06-30   | $0.14B  | 32.10%        |
| 2025-03-31   | $0.12B  | 28.76%        |
| 2024-12-31   | $0.13B  | 27.81%        |
| 2024-09-30   | $0.10B  | 26.71%        |

**Analysis:** Revenue and Profit Margin are both increasing on a quarterly basis. This is a positive development for RKLB's financial health.

**Capital and Profitability:**

| Quarter      | Equity  | ROE      |
|--------------|---------|----------|
| 2025-09-30   | $1.28B  | -1.43%   |
| 2025-06-30   | $0.69B  | -9.65%   |
| 2025-03-31   | $0.43B  | -14.05%  |
| 2024-12-31   | $0.38B  | -13.69%  |
| 2024-09-30   | $0.42B  | -12.37%  |

**Analysis:** Equity has significantly increased, especially in the most recent quarter. While ROE (Return on Equity) is still negative, it is improving. The large increase in equity likely reflects capital raises or other financing activities.

**7. Comprehensive Analysis**

Rocket Lab (RKLB) has demonstrated strong revenue growth and significantly outperformed the S&P 500 in recent years.  While it is not yet profitable, the trend in both EPS and ROE is positive. The company's high growth is reflected in the substantial increase in its market capitalization.

**Key Positives:**

*   **High Growth Potential:** Strong revenue growth, improving profitability metrics, and a high Alpha suggest potential for continued growth.
*   **Market Outperformance:** Significantly higher returns than the S&P 500.
*   **Positive Momentum:** Positive PPO and recent divergence indicate short-term upward price momentum.
*   **Analyst Target Price:** The average analyst target price suggests potential upside.

**Key Risks/Considerations:**

*   **High Volatility:** The high MDD and RSI close to overbought levels indicates significant price volatility.
*   **Lack of Profitability:** The company is not yet profitable, although it is moving in the right direction.
*   **News Driven Volatility:** Recent news illustrates the stock's sensitivity to company announcements and mission success.
*   **Beta Close to Zero:** Implies a lack of correlation to the rest of the market.
*   **Relatively High Valuation:** With current trends, it may or may not be sustained.

**Investment Recommendation (Based on data provided):**

The data presents a mixed picture. A medium investment recommendation seems reasonable based on the MRI, positive growth trends, and expected returns. However, investors should be aware of the high volatility and speculative nature of the stock and conduct thorough due diligence before investing. It would be very risky to invest all of the cash as the "Hybrid Signal" implies. Given the stock's sensitivity to news, monitoring company announcements and industry developments is crucial.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.